Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$110.31 - $140.45 $54,493 - $69,382
-494 Reduced 4.36%
10,847 $1.23 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $34,837 - $42,730
305 Added 2.76%
11,341 $1.57 Million
Q4 2023

Feb 12, 2024

BUY
$75.49 - $124.16 $833,107 - $1.37 Million
11,036 New
11,036 $1.37 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $57,191 - $82,556
673 Added 4.74%
14,869 $1.68 Million
Q2 2022

Aug 16, 2022

BUY
$67.99 - $132.89 $965,186 - $1.89 Million
14,196 New
14,196 $1.06 Million
Q3 2019

Nov 13, 2019

SELL
$35.53 - $43.8 $1.43 Million - $1.76 Million
-40,262 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$27.84 - $38.92 $86,498 - $120,924
3,107 Added 8.36%
40,262 $6.03 Million
Q1 2019

May 13, 2019

SELL
$28.07 - $38.18 $841,117 - $1.14 Million
-29,965 Reduced 44.64%
37,155 $4.43 Million
Q4 2018

Feb 13, 2019

BUY
$26.99 - $37.37 $192,600 - $266,672
7,136 Added 11.9%
67,120 $8.04 Million
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $8,125 - $12,778
348 Added 0.58%
59,984 $8.58 Million
Q2 2018

Sep 27, 2018

SELL
$17.54 - $25.22 $762,656 - $1.1 Million
-43,481 Reduced 42.17%
59,636 $5.66 Million
Q2 2018

Aug 10, 2018

BUY
$17.54 - $25.22 $1.04 Million - $1.5 Million
59,389 Added 135.81%
103,117 $6.83 Million
Q1 2018

May 14, 2018

BUY
$13.06 - $18.54 $234,818 - $333,349
17,980 Added 69.83%
43,728 $3.24 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $817,653 - $1.13 Million
-73,530 Reduced 74.06%
25,748 $1.48 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $1.13 Million - $1.88 Million
99,278
99,278 $4.86 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.